Cytoprotection Alternatives for Cancer Treatment: In-vitro Evaluation of Alpinia Zerumbet as a Radioprotective Agent
Abstract
Cancer radiotherapy and modern synthetic medicine are critical for the treatment of cancer patients, but on the other hand they may have tremendous harmful side effect from the point of view of a weakened immune system. The focus of current research efforts in the industry and academia is not only to find affordable treatment methodologies but also to discover sources that mitigates or prevents the negative impact of these treatments on the patient’s immune system. This review will provide details of optimal methodology involving Invitro application of techniques such as phytochemical analysis, thin layer chromatography, cytogenetic analysis that were adopted to assess the efficacy of Alpinia Zerumbet extracts as a radioprotector. These methodologies provide a holistic evaluation technique for assessing any potential cytoprotective agent, especially if it’s from the herbal domain. As a case study, analytical and inferential results summary of the research conducted to assess radioprotective property of Alpinia Zerumbet, a herbal and readily available derivative, will be presented. The key findings from the research indicate that the Alpinia Zerumbet extract has potential to be an effective radioprotector, with minimal side effects as compared to synthetic chemical cytoprotective agents.
Keywords: Radioprotection; cancer; herbal; Alpinia Zerumbet
DOI
https://doi.org/10.22270/jddt.v9i4-s.3268References
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R.L., Torre, L.A., Jemal, A., Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, 2018.
Prof Robert G Bristow, Brian Alexander, Michael Baumann, Combining precision radiotherapy with molecular targeting and immunomodulatory agents: a guideline by the American Society for Radiation Oncology. The Lancet Oncology Volume 19, Issue 5, May 2018
Brizel DM., Wasserman TH, Henke M., Strand V., Rudat V., Monniar A., Sauer R, Phase III Radiomized trail of amifostine as a radioprotector in head and neck cancer J clin oncol, 2000, 18 (19); 3339-45.
Karbownik M, Reiter R.J., antioxidant effect of melatonin in protection against cellular damage, caused by ionizing radiation, Proc soc Exp Bio med. 225; 2010, 9-22.
Agrawal P.K., Goel H.C., Protective effect of RH-3 with special reference to radiation-induced micronuclei in mice bone marrow, 40; 2002, 525-530.
Pullaiah T. : “Encyclopedia of Word Medicinal Plants”, Regency Publications , New Delhi, Vol.I , 2006, p.124-127.
Elzaawely, A.A. et al., Essential oils, kava pyrones and phenolic compounds from leaves and rhizomes of Alpinia zerumbet (Pers.) and their antioxidant activity. Food Chemistry, 2007, 103 (2); 486-494.
Yun-pengJiab, Ting-yu Shiac,Yan-yan ,Zhanga Dan, Lina Ke-gang, Linghua Yi-ni, Xua Ling Tao,Qing Lud, Xiang-chun Shena "Essential oil from Fructus Alpinia zerumbet (fruit of Alpinia zerumbet (Pers.) Burtt.et Smith) protected against aortic endothelial cell injury and inflammation in vitro and in vivo": Journal of Ethnopharmacology Volume 237, 2019, Pages 149-158
Elzaawely, A.A., T.D. Xuan and S. Tawata : “Antioxidant activity and contents of essential oil and phenolic compounds in flowers and seeds of Alpinia zerumbet (Pers.) B.L. Burtt. and R.M. Sm.”. Food Chem., 104: 2007, 1648-165
Rosalind J Hastings, Nick Bown, Maria G Tibiletti, Maria Debiec-Rychter, Roberta Vanni, Blanca Espinet, Nadine van Roy, Paul Roberts, Eva van den Berg-de-Ruiter, Alain Bernheim, Jacqueline Schoumans, Steve Chatters, "Guidelines for cytogenetic investigations in tumours" European Journal of Human Genetics, 2015,: 42-48
Published


How to Cite
Issue
Section
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).